Maintenance of general anesthesia in pediatric clients, aged 1-12 years. Epidural or intrathecal use due to the presence of glycine in the formulation. Hypersensitivity to fentanyl analogues. Use as the sole agent in general anesthesia because LOC cannot be ensured and due to a high incidence of apnea, muscle rigidity, and tachycardia. Respiratory depression and other narcotic effects may be seen in newborns whose mothers are given remifentanil shortly before delivery.
Geriatric clients are twice as sensitive as younger clients to the effects of the drug.
Not studied in children less than 2 years of age. Shivering, fever, dizziness, headache, agitation, chills, warm sensation, anxiety, involuntary movement, prolonged emergence from anesthesia, tremors, disorientation, dysphoria, nightmares, hallucinations, paresthesia, nystagmus, twitch, sleep disorder, seizures, amnesia. Hypotension, bradycardia, tachycardia, hypertension, atrial and ventricular arrhythmias, heart block, ECG change consistent with myocardial ischemia, syncope. Muscle rigidity, muscle stiffness, musculoskeletal chest pain, delayed recovery from neuromuscular block. Respiratory depression, apnea, hypoxia, cough, dyspnea, bronchospasm, laryngospasm, rhonchi, stridor, nasal congestion, pharyngitis, pleural effusion, hiccoughs, pulmonary edema, rales, bronchitis, rhinorrhea.